IMVT
ImmunovantยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
IMVT Profile
Immunovant, Inc.
A clinical-stage biopharmaceutical company that developing therapies for autoimmune diseases
320 West 37th Street, New York, NY 10018
--
Immunovant, Inc., incorporated in Delaware on December 6, 2018, is a clinical-stage biopharmaceutical company focused on providing a normal life for patients with autoimmune diseases.
